Nuclear transport modulators and uses thereof
US9266843B2 · kind B2 · utility
28Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2013 |
| Grant date | Feb 23, 2016 |
| Priority date | — |
| Expiry date | May 9, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I:and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I, and methods of using the compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.